Jeffrey Kindler - Mar 14, 2024 Form 4 Insider Report for PRECIGEN, INC. (PGEN)

Role
Director
Signature
/s/ Jeffrey B. Kindler, by Donald P. Lehr, as attorney-in-fact
Stock symbol
PGEN
Transactions as of
Mar 14, 2024
Transactions value $
$68,999
Form type
4
Date filed
3/18/2024, 06:16 PM
Previous filing
Mar 12, 2024
Next filing
May 16, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PGEN Common Stock Award $69K +48.3K +13.98% $1.43 393K Mar 14, 2024 Direct F1

Derivative Securities (e.g., puts, calls, warrants, options, convertible securities)

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Underlying Class Amount Exercise Price Ownership Footnotes
transaction PGEN Restricted Stock Units Award $0 +87.4K $0.00 87.4K Mar 14, 2024 Common Stock 87.4K Direct F2, F3
transaction PGEN Option to Purchase Common Stock (Right to Buy) Award $0 +102K $0.00 102K Mar 14, 2024 Common Stock 102K $1.43 Direct
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The shares were issued to the reporting person in lieu of an annual retainer of $68,999.
F2 Each restricted stock unit ("RSU") represents a contingent right to receive one share of Precigen common stock.
F3 The RSUs vest in full on March 14, 2025.